(HealthDay News) — Cannabidiol (CBD) appears safe and may reduce anxiety in patients with advanced breast cancer, according to a study published in JAMA Network Open.

a 29.5% reduction in State-Trait Anxiety Inventory (STAI) scores, and a 61.7% reduction in Visual Analog Scale (VAS) scores. The DAS/BF group exhibited comparable reductions, indicating that VR ...

Anxiety levels among participants were assessed using the Visual Analog Mood Scale (VAMS) prior to and 2-to-4 hours following the treatment drug ingestion. Participants who were randomly assigned ...

Anxiety was assessed by scores on the ‘afraid’ component of the Visual Analog Mood Scale (VAMS), measured before and 2-4 hours after ingestion of CBD. The scores were then used to assess ...

(HealthDay News) — For patients with advanced breast cancer and baseline clinical anxiety ... scores on the afraid subscale of the Visual Analog Mood Scale (VAMS) before and 2 to 4 hours ...

A preliminary randomized clinical trial establishes CBD as a treatment for anxiety in patients with ... on the afraid subscale of the Visual Analog Mood Scale (VAMS) before and 2 to 4 hours ...